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Escherichia coli K (JM109) and E. coli B (BL21) are strains used routinely for recombinant protein production. These two strains grow and
respond differently to environmental factors such as glucose and oxygen concentration. The differences have been attributed to differential
expression of individual genes that constitute certain metabolic pathways that are part of the central carbon metabolism. By implementing a
semiparametric algorithm, which is based on a density ratio model, it was possible to compare and quantify the expression patterns of groups of
genes involved in several central carbon metabolic pathways. The groups comprising the glyoxylate shunt, TCA cycle, fatty acid, and
gluconeogenesis and anaplerotic pathways were expressed differently between the two strains, whereas no differences were apparent for the
groups comprising either glycolysis or the pentose phosphate pathway. These results further characterized differences between the two E. coli
strains and illustrated the potency of the semiparametric algorithm.
© 2006 Elsevier Inc. All rights reserved.Keywords: Microarray; E. coli; Glucose metabolism; Semiparametric algorithmFollowing gene transcription with microarrays is currently
the preferred method for evaluating either gene expression
variations between different cells or the effects of various
compounds and environmental conditions on gene expression.
With the use of commercially available software, such as Partek
Genomics Suite or Acuity, microarray data can be organized to
highlight specific genes or to identify entire biological pathways
[1]. The level of gene organization depends on the algorithms
being used to search the data for possible correlations,
groupings, and patterns [2]. From a statistical standpoint, a
critical aspect of evaluating microarray data is determining
whether the expression levels of certain genes or groups of
genes are truly different from one another [3,4]. For this type of
comparative analysis, a number of hypothesis testing methods
are commonly used, such as classical t test, F test, and
ANOVA, each with advantages and limitations depending on
the exact application [5,6].⁎ Corresponding author. Fax: +1 301 451 5911.
E-mail address: yossi@nih.gov (J. Shiloach).
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doi:10.1016/j.ygeno.2006.10.004It was previously established that the growth behavior and
metabolite production patterns of Escherichia coli K (JM109)
and E. coli B (BL21) are very different [7,8]. Most importantly,
E. coli B is insensitive to high glucose concentration and does
not produce acetate, which is believed to affect both growth
and protein production adversely. In contrast, E. coli K is very
sensitive to glucose concentration and produces high levels of
acetate. As a result, intensive work was conducted to
understand the differences between the two strains by
comparing their central carbon metabolism. This was done
by analyzing growth characteristics and acetate production [7],
performing flux analysis [8], following carbon flow using
labeled carbon [9], and following individual gene transcription
using Northern blot analysis and cDNA microarrays [10,11]. In
the presented work, a statistical semiparametric algorithm [12]
was implemented for evaluating previous results by comparing
the transcription of groups of genes belonging to specific
metabolic pathways of the central carbon metabolism. This
algorithm analyzed microarray results by employing both
computational and graphical components. The computational
Fig. 1. Bacterial growth, acetate production, and glucose consumption at high
initial glucose concentration of E. coli strains, (A) E. coli BL21 and (B) E. coli
JM109. The arrows indicate sampling time for microarray analysis.
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distributions, and then correlated differences between data
sets that had distinct distributions with commonly used p values.
The graphical component used calculated log2 numbers that
were obtained from the intensity values and plotted them along
the x axis, while the estimated density functions were plotted
along the y axis.
A list of the genes involved in the glyoxylate shunt, TCA
cycle, glycolysis, pentose phosphate pathway, combined
gluconeogenesis and anaplerotic pathways, and fatty acid
pathway was assembled. Bacterial samples were collected and
analyzed using oligonucleotide microarrays. Normalized
intensity values for each gene within a specific pathway
were then used as input for the semiparametric algorithm and
to evaluate the differences between the pathways of the two
strains.
Results
E. coli B (BL21) and E. coli K (JM109) were grown at an
initial glucose concentration of 40 g/L (Fig. 1) and their gene
transcription was analyzed using oligonucleotide arrays.
Samples for microarray analysis were taken at the end of the
logarithmic growth phase, when the glucose concentration was
below 1 g/L. Genes were then grouped according to the
pathways glyoxylate shunt, TCA cycle, glycolysis, pentose
phosphate, fatty acids, and gluconeogenesis and anaplerotic,
each consisting of 5 to 18 genes. Three separate fermentations
were conducted with samples from each run being assayed
using microarrays. The resulting data, in the form of gene-
specific signal intensity values, are summarized in Table 1.
These data were then used as input for the semiparametric
algorithm, the results of which are shown in Table 2 and Fig. 2.
Table 2 provides the p values for each pathway, while Fig. 2
provides plots of the estimated density functions for both E. coli
strains vs log2 of the average intensity values. Gene-specific
intensity values from the three different arrays were averaged
and converted to log2 values for each E. coli strain. (This log2
conversion is the reason for the difference between the intensity
values listed in Table 2 and the values in found along the x axis
in the plots of Fig. 2.)
As shown in Table 2, the glyoxylate shunt, TCA cycle, and
fatty acid pathways are distributed differently between the two
E. coli strains because their p values are much smaller than 0.05
(0.0068, 0.0005, and 0.0238, respectively), which was set to
correspond to the likelihood of occurrence of 5% [13].
Acceptance of the null hypothesis of equal distribution takes
place for p values greater than the limit of 0.05. Conversely, p
values below the limit of 0.05 correspond to rejection of the null
hypothesis. In other words, the genes that collectively constitute
each of the three pathways listed above are being expressed
differently between the two E. coli strains, and these differences
are less than 5% likely to occur naturally, taking also into
consideration inherent variability between slides, sample
preparation, etc. [14]. In fact, the glyoxylate shunt and the
TCA cycle have such low p values that the likelihood of these
distributions occurring naturally is a fraction of 1% (0.68 and0.05%, respectively). Figs. 2A, 2B, and 2E graphically illustrate
the differences between the two E. coli strains for the three
pathways. No point-specific overlaps or structural similarities
are apparent in any of these graphs.
The gluconeogenesis and anaplerotic pathway has a p value
only slightly larger than the limit of 0.05 (0.0592) and therefore
the genes in this pathway are also being expressed differently
between the two strains, but not as significantly as the
previously mentioned pathways. Fig. 2F highlights the
differences and similarities between the two strains for this
pathway. Despite some common features between the two
curves, such as the slope of the initial ascent, there are several
important differences, such as the well-defined peak in the E.
coli JM109 curve and the rapid descent of the curve for higher
values of x compared with the E. coli BL21 curve.
For the glycolysis and the pentose phosphate pathways, no
differences were apparent, as evidenced by their relatively large
p values (0.6142 and 0.2964, respectively). In both Figs. 2C and
2D the curve for one strain traces the curve for the other strain.
Both figures have points of overlap and nearly identical shapes;
therefore, the genes constituting each of these two pathways
behave similarly between the two E. coli strains.Discussion
Microarrays are an efficient tool for the identification of gene
transcription differences between cells, tissues, and micro-
organisms [15]. They have been used extensively for studying
Table 1
Microarray data in the form of normalized signal intensities, used as input for the
algorithm
Gene symbol Signal intensity
BL21 Batch No. JM109 Batch No.
1 2 3 1 2 3
Glyoxylate shunt
aceA 1961 920 9329 257 332 158
aceB 1427 2663 5448 246 245 145
aceK 312 196 446 149 238 197
iclR 159 323 656 349 92 171
fadR 498 490 485 556 317 526
fruR 456 273 242 229 47 225
himA 12,631 5377 12,753 4146 3491 3227
himD 7171 5304 20,350 5166 3517 5730
TCA cycle
acnA 2332 661 1361 1831 2919 1847
acnB 4671 3524 6634 2900 3082 1661
icdA 4547 9686 10,406 8756 7511 4768
sucA 4977 6101 2902 2870 6574 728
sucB 7728 9698 5137 3958 6922 915
sucC 14,842 14,685 8499 6757 7490 1866
sucD 2393 2615 1849 1845 1593 603
sdhA 4126 8633 5329 2941 7560 1955
sdhB 2050 3725 1454 1046 2427 629
sdhC 1082 4757 1500 331 971 430
sdhD 4090 9170 5372 1104 4336 1628
fumA 3702 4071 4013 1340 3395 1074
mdh 8393 7132 7670 5801 3695 1437
gltA 7182 10,969 8510 3085 8217 2575
Glycolysis pathway
glk 542 1368 620 383 422 350
pgi 1337 833 534 1699 1530 906
pfkA 1955 1636 1709 2548 2003 2386
pfkB 2084 503 1639 1017 1501 778
fba 2013 3185 2408 3729 3722 1199
tpiA 2490 1799 2241 1329 1427 1394
gapA 4684 15,341 7454 15,938 14,089 7851
pgk 1749 2640 2478 4521 4491 2979
gpmA 2437 2384 3860 4215 4107 2116
eno 4677 3717 2965 6521 3889 2980
pykA 1802 1812 2527 1044 1065 978
pykF 2687 1100 1724 1695 1302 2060
pyrB 519 363 259 240 244 259
pgm 607 1176 644 533 515 430
manA 693 764 687 1054 1420 890
mgsA 1541 2058 1814 717 505 623
Pentose phosphate
gcd 164 70 365 551 973 588
gntK 2548 5833 640 37 206 195
gntP 374 323 405 232 246 139
gntR 212 687 462 858 807 692
gntT 4158 6040 2235 337 553 308
gntU_1 234 622 268 73 93 109
gntU_2 426 669 145 55 145 152
zwf 859 1189 757 2074 1770 1781
gnd 633 1432 941 5216 4284 3423
rpe 115 787 353 235 188 213
rpiA 1802 1396 1462 1356 1341 1382
rpiB 551 566 399 355 387 225
talA 4304 372 3102 4366 5600 1778
talB 2554 2446 2022 1804 2014 2295
talC 86 38 44 16 15 23
Table 1 (continued)
Gene symbol Signal intensity
BL21 Batch No. JM109 Batch No.
1 2 3 1 2 3
Pentose phosphate
tktA 924 1149 843 969 559 300
tktB 1759 129 1220 1989 3296 784
eda 928 1697 928 1537 1369 1214
Fatty acid
fabA 207 845 693 1070 834 1210
fabB 3785 5922 5729 5061 5983 3950
fabD 1486 2355 1451 1570 1095 822
fabF 178 931 498 356 153 333
fabG 2683 4035 2195 2405 1855 1672
fabH 988 1581 1207 1476 1203 1041
fabI 839 1592 3343 4860 2927 2733
fabZ 778 2424 1699 1705 1378 2064
fadA 301 164 2175 252 449 215
fadB 904 1256 6194 78 282 85
fadD 1190 915 2224 366 407 220
fadL 2219 744 5804 31 28 85
fadR 498 490 485 556 317 526
Gluconeogenesis and anaplerotic pathway
fbp 2062 2400 2871 1805 1166 870
pckA 5721 4041 5127 1929 1955 563
ppsA 2162 1261 2053 455 389 270
ppc 728 3105 607 1099 685 763
sfcA 195 584 179 810 721 473
302 J.-N. Phue et al. / Genomics 89 (2007) 300–305genotypic causes for phenotypic differences, divergent
responses to environmental pressures, and evolutionary trends.
A typical array experiment generates a large amount of data that
requires statistical methods to perform searches to detect and
quantify differences between gene expression levels [16,17]. In
most cases, the result of such a search is a list of up-regulated
and down-regulated genes, relative to a reference or control
gene expression pattern.
E. coli JM109 and E. coli BL21 are two strains commonly
used for recombinant protein production. These two strains are
different in their response to glucose concentration, especially
excess glucose. E. coli JM109 excretes high levels of acetateTable 2
Results of the semiparametric algorithm applied to normalized microarray data
from six hybridized oligonucleotide arrays
Pathway n α1 β1 χ1 p value
Glyoxylate shunt 24 3.284 –0.344 7.325 0.0068
TCA cycle 42 8.827 –0.755 12.303 0.0005
Glycolysis 48 0.835 –0.079 0.254 0.6142
Pentose phosphate 54 0.994 –0.108 1.090 0.2964
Fatty acid 39 3.327 –0.337 5.111 0.0238
Gluconeogenesis and anaplerotic 15 5.712 –0.567 3.559 0.0592
Symbols are as follows: n, number of data points for a given pathway; α1,
calculated parameter as defined in Eq. (1); β1, calculated parameter as defined in
Eq. (1) and the main component of null hypothesis;χ1, test statistic as defined in
Eq. (2) used to quantify similarities between data distributions; p value, the
significance probability under the null hypothesis that the test statistic defined in
Eq. (2) takes a value larger than its observed value.
Fig. 2. Comparison of the reference density function (E. coli BL21) and the distortion density function (E. coli JM109) vs log2 of average intensity values for each of
the following pathways: (A) glyoxylate shunt, (B) TCA cycle, (C) glycolysis, (D) pentose phosphate, (E) fatty acid, (F) gluconeogenesis and anaplerotic.
303J.-N. Phue et al. / Genomics 89 (2007) 300–305when the glucose concentration exceeds a few grams per liter,
whereas E. coli BL21 is insensitive to glucose concentrations
and excretes low levels of acetate even when the glucose
concentration is above 30 g per liter. Even when a careful study
of the central carbon metabolism of these strains was done by
enzymatic activity, metabolic flux analysis, and cDNA arrays
[11], several differences in the metabolic pathways were
identified. The cDNA array analysis enabled us to determine in
which strain and under what growth conditions would the
transcription of a particular gene be higher or lower. However,
it was not possible to compare directly and evaluate the
expression levels of groups of genes constituting specific
pathways such as glycolysis, TCA cycle, or the glyoxylate
shunt. This comparison was needed for a comprehensive
picture of the strains’ metabolic behavior and was possible to
perform by using a semiparametric algorithm. Results
generated from the implementation of this algorithm indicated
that the transcription of the glycolysis and the pentose
phosphate pathways was comparable in the two strains;however, clear differences were identified in the transcription
of the TCA cycle, glyoxylate shunt, and fatty acid pathways
and, to a lesser extent, in the gluconeogenesis and anaplerotic
pathway. Differences in the growth rate and the metabolic
patterns, including acetate formation between the two E. coli
strains, can therefore be attributed to the combined effects of
the glyoxylate shunt, TCA cycle, gluconeogenesis, and fatty
acid pathways. In fact, this difference in gene transcription
patterns is very likely the reason for efficient utilization of
glucose through both the TCA cycle and the glyoxylate shunt,
as well as assimilation of acetate via gluconeogenesis and fatty
acid biosynthesis in E. coli BL21. The work presented in this
article therefore supports previous information demonstrating
that the glyoxylate shunt enzymes were more active in E. coli
B than in K and that certain TCA, gluconeogenesis and
anaplerotic, and fatty acid metabolism genes are transcribed
differently between the two strains. However, it was not
possible to demonstrate that the transcription patterns of an
entire pathway were different.
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semiparametric algorithmwas chosen because it has been shown
to be robust, relatively insensitive to outliers, and readily capable
of analyzing an assortment of number sets, irrespective of their
origin [18]. The work presented focused on using results from
hybridized oligonucleotide arrays as input for the semipara-
metric algorithm, but the overall process presented here is
applicable to cDNA arrays as well. This, however, will require a
universal control sample to be used with each dual-channel
cDNA slide to allow cross-comparisons, a limitation not
encountered with single-channel oligonucleotide arrays since
only one sample is hybridized per slide instead of two samples
(test and control).
The results of this study demonstrate the benefit of the
semiparametric algorithm to validate and expand upon informa-
tion obtained from genomic microarrays. The purpose of this
study was to present a comprehensive approach involving the
implementation of a statistical method to microarray data in
order to validate and expand upon previous results. As such, the
method presented offers researchers another way to decipher
microarray data and explore genomic differences in the context
of entire biological pathways.Materials and methods
Statistical formulation
The semiparametric method used in this work generates both numerical
values (p values) and graphical illustrations to highlight distinctions between
genes or groups of genes [12,19–21]. Suppose that a set of gene-specific intensity
values labeled x11, x12, …, x1m is distributed such that a probability density
function g1(x) can describe the distribution of these m numbers. Another set of
gene-specific intensity values labeled x21, x22, …, x2n is distributed such that a
probably density function g(x) can describe the distribution of these n numbers
[22]. As part of this mathematical construct, m and nmay be different; however,
for some h(x) the following equation is assumed,
g1ðxÞ ¼ expfa1 þ b1hðxÞggðxÞ; ð1Þ
whereα1 andβ1 are unknown parameters that can be estimated from the data sets
(i.e., x11, x12, …, x1m; x21, x22, …, x2n) and h(x) is a function that must be
specified. This equation expresses g(x) as a baseline or reference density while
calculating the deviation or “tilt” associated with g1(x) in terms of the reference
density. In other words, Eq. (1) illustrates the mathematical relationship between
g(x) and g1(x), the reference density function and the deviation density function,
respectively.
This setup allows for testing the null hypothesis of equal distribution; that is
g1(x)=g(x) and (H0) β1=0. Incorporating the idea of a null hypothesis allows
insight into subsequent analysis [19]. Accepting the null hypothesis, β1=0,
signifies that g1(x) and g(x) are equal. If the null hypothesis is rejected, then g1
(x)≠g(x); hence there is a difference between the distributions of these two data
sets [20]. To test the hypothesis, a test statistic, χ1, is designated. It is
asymptotically distributed as χ1
2 with 1 degree of freedom and adheres to the
equation
v1 ¼ mþ nð Þ
q1
ð1þ q1Þ2
̂Var h tð Þð Þ ̂b21 ð2Þ
where ρ1=m/n, Vˆar(h(t)) is the estimate of the variance of h(t) with respect to
the reference distribution g(x), and βˆ1 is the estimate of β1 [18]. For our
microarray data sets, m=n=the number of genes in a particular pathway times
the number of arrays spotted with each gene, 3 in this case, because that was how
many arrays were hybridized per E. coli strain [22].The semiparametric algorithm makes no assumptions regarding normal
distributions for either g(x) or g1(x). The only assumption made is for h(x). The
choice of h(x)=x is quite satisfactory for symmetric or nearly symmetric
probability distributions, whereas h(x) = log x is adequate for skewed
distributions. In our analysis we utilized h(x)=x [21].
The algorithm quantifies the level of similarity between g(x) and g1(x) by
numerical and graphical means. The numerical approach calculates the p values
resulting from the hypothesis test, discussed earlier. The graphical approach
(seen in Fig. 2) is an integral part of the analysis and not simply an illustration.
The graphical approach highlights the differences between the two E. coli strains
for a specific biological pathway, indirectly correlates p values with the overall
structure and predictability of the density functions, and demonstrates how a
series of numbers, in this case the intensity values, can be averaged and
combined into a new data set independent of the original source, in this case, the
genes. In other words the graphical approach both visualizes and interprets the
results generated by the semiparametric method, as shown in Fig. 2. The greater
the similarity between the distributions of a given pathway, the closer the plots of
the estimated g(x) and g1(x) are one to another, and the higher the corresponding
p value.
Bacterial strains
The two E. coli strains studied were BL21 (λDE3) (F−, ompT, hsdSB (rB
−,
mB
+), dcm, gal, (DE3), Cmr) and JM109 (DE3) (endA1, recA1, gyrA96, thi,
hsdR17 (rk
−,mk
+), relA1, supE44, λ−, Δ(lac-proAB), [F′, traD36, proAB, lacI-
ZΔM15], λDE3). Both strains were obtained from Promega Corp. (Madison,
WI, USA).
Fermentation and sample preparation
Both strains were grown at 37°C in modified LB medium containing 10 g/L
tryptone, 5 g/L yeast extract (15 g/L for JM109), 5 g/L NaCl, and 5 g/L K2HPO4.
After sterilization, 10 mM MgSO4, 1 ml/L trace metal solution, and 40 g/L
glucose were added. Overnight cultures grown at 37°C were used to inoculate
4.0 L of medium in a B. Braun fermentor equipped with data acquisition and a
control system. The cultures were grown to high cell density, the pH was
controlled at 7.0 by the addition of 50%NH4OH, and dissolved oxygen was kept
above 30% of saturation at all times.
Samples for total RNA purification were collected at the late logarithmic
phase of growth, indicated by arrows in Fig. 1. Next, the samples were
centrifuged at 14,000g for 10 min at 4°C; the supernatant was removed and the
pellets were quickly frozen with dry ice and stored at −80°C.
Total RNA preparation
Total RNA was isolated using a MasterPure RNA purification kit
(Epicentre Technologies, Madison, WI, USA) according to the manufacturer’s
protocol (Kit MCR 85102). Isolated RNAwas further purified with an RNeasy
Kit 75144 (Qiagen). Overall RNA concentration was determined by measuring
absorbance at 260 nm (A260) using a GeneQuant Pro (Amersham Biosciences).
Purified RNA samples were determined to have absorbance ratios (A260/A280)
of 1.85–1.95 and by running on a 1% agarose/formaldehyde denaturing gel. To
ensure equivalency between individual samples further, the 23S and 16S
ribosomal RNAs (rRNAs) from each sample were analyzed by an Agilent 2100
bioanalyzer (Agilent Technologies). The intensity of each band was calculated
and the rRNA ratio (23S/16S) for each sample was calculated to be greater
than 1.5.
Oligonucleotide microarrays
Standard methods available from Affymetrix (Santa Clara, CA, USA) for
cDNA synthesis, fragmentation, and end-terminus biotin labeling starting with a
total RNA (10 μg) sample were used. The biotin-labeled cDNAwas hybridized
to E. coli Affymetrix antisense genome arrays at 45°C for 16 h as recommended
in the GeneChip technical manual (Affymetrix). Hybridized arrays were stained
with streptavidin–phycoerythrin using an Affymetrix Fluidic Station. The
GeneChips were scanned using an Affymetrix/Hewlett–Packard GeneArray
305J.-N. Phue et al. / Genomics 89 (2007) 300–305GC2500 scanner. The signal intensity was normalized using Affymetrix
Microarray Suite software (version 4.0).
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